1652.HK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 05:09):

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China...

Stats
Dagens volum	111 000
Gjennomsnittsvolum	104 864
Markedsverdi	615.44M
EPS	HKD0 ( 2023-08-29 )
Neste inntjeningsdato	( HKD0 ) 2024-05-28
Last Dividend	HKD0.00420 ( 2022-06-07 )
Next Dividend	HKD0 ( N/A )
P/E	-16.60
ATR14	HKD0 (0.00%)

Fusen Pharmaceutical Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Fusen Pharmaceutical Økonomi

Annual	2023
Omsetning:	HKD565.61M
Bruttogevinst:	HKD299.51M (52.95 %)
EPS:	HKD-0.0500

FY	2023
Omsetning:	HKD565.61M
Bruttogevinst:	HKD299.51M (52.95 %)
EPS:	HKD-0.0500

FY	2022
Omsetning:	HKD491.76M
Bruttogevinst:	HKD225.02M (45.76 %)
EPS:	HKD-0.0458

FY	2021
Omsetning:	HKD385.66M
Bruttogevinst:	HKD211.13M (54.75 %)
EPS:	HKD0.0210

Financial Reports:

No articles found.

Fusen Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Fusen Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 1.583 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	HKD0.00620	2018-09-13
Last Dividend	HKD0.00420	2022-06-07
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	8	--
Total Paid Out	HKD0.0436	--
Avg. Dividend % Per Year	0.00%	--
Score	1.1	--
Div. Sustainability Score	1.583
Div.Growth Potential Score	0
Div. Directional Score	0.0721	--

Next Divdend (Est)
(2024-08-30)

HKD0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.10

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9909.HK	Ex Dividend Knight	2023-11-24	Semi-Annually	0.00%
2161.HK	Ex Dividend Junior	2023-08-15	Annually	0.00%
1161.HK	Ex Dividend Knight	2023-06-12	Annually	0.00%
0239.HK	Ex Dividend Knight	2023-09-29	Semi-Annually	0.00%
3866.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%
1731.HK	Ex Dividend Junior	2023-06-23	Sporadic	0.00%
0771.HK	Ex Dividend Junior	2023-05-31	Sporadic	0.00%
2327.HK	Ex Dividend Junior	2023-08-03	Sporadic	0.00%
1290.HK	Ex Dividend Junior	2023-06-14	Sporadic	0.00%
0363.HK	Ex Dividend Knight	2023-06-01	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0641	1.500	-1.283	-1.924	[0 - 0.5]
returnOnAssetsTTM	-0.0270	1.200	-0.900	-1.080	[0 - 0.3]
returnOnEquityTTM	-0.0612	1.500	-1.791	-2.69	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.853	0.800	-0.735	-0.588	[1 - 3]
quickRatioTTM	0.329	0.800	-2.77	-2.22	[0.8 - 2.5]
cashRatioTTM	0.0524	1.500	-0.820	-1.230	[0.2 - 2]
debtRatioTTM	0.255	-1.500	5.75	-8.62	[0 - 0.6]
interestCoverageTTM	6.34	1.000	8.76	8.76	[3 - 30]
operatingCashFlowPerShareTTM	-0.0619	2.00	-0.0206	-0.0412	[0 - 30]
freeCashFlowPerShareTTM	-0.118	2.00	-0.0590	-0.118	[0 - 20]
debtEquityRatioTTM	0.609	-1.500	7.57	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.530	1.000	4.51	4.51	[0.2 - 0.8]
operatingProfitMarginTTM	0.0379	1.000	-1.241	-1.241	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.135	1.000	-1.862	-1.862	[0.2 - 2]
assetTurnoverTTM	0.421	0.800	-0.527	-0.422	[0.5 - 2]
Total Score				1.583

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-17.20	1.000	-1.838	0	[1 - 100]
returnOnEquityTTM	-0.0612	2.50	-1.151	-2.69	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.118	2.00	-0.0393	-0.118	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.0619	2.00	-0.0206	-0.0412	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0819	1.000	-4.55	0	[0.1 - 0.5]
Total Score				-1.438

Fusen Pharmaceutical

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.